TOP TIERMARKET NEWSWIRE
News & sentiment

AIM IMMUNOTECH INC (AIM) — News & AI sentiment

AIM IMMUNOTECH INC (AIM) news roundup. 7 stories aggregated over the last 30 days. Average 30-day sentiment is 58.6/100. Recent insider activity (SEC Form 4, 90-day window): 6 purchases totalling $24K and 0 sales totalling $0 — net buying of $24K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
7
avg sentiment 58.6/100
Insider net (90d)
$24K
6 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

AIM news in the last 24 hours, 7 days, 30 days and 90 days

How much AIM coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAIM storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days758.6/100AIM headlines →
Last 90 days3156.9/100AIM headlines →

Latest stories on AIM

Oct 7
Oct 7
Oct 5
Oct 5
Oct 1
Sep 30
Sep 30
Sep 25
Sep 22
Sep 22
Sep 22
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
Sep 14
Sep 10
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
Sep 10
Sep 9
Sep 9
Sep 4
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
Sep 4
Sep 2
AIM ImmunoTech granted patent for Ampligen
The Fly63 · neutralproduct/pr
Aug 31
Aug 31
Aug 31
Aug 27
Aug 12
Aug 11
Open AIM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →